Ultrasound Liver Fat Quantification on Pediatric Patients - Trial NCT06095479
Access comprehensive clinical trial information for NCT06095479 through Pure Global AI's free database. This phase not specified trial is sponsored by Philips (China) Investment CO., LTD and is currently Recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Philips (China) Investment CO., LTD
Timeline & Enrollment
N/A
Jul 06, 2021
Jun 30, 2024
Primary Outcome
Rate of HRIQ, AttenQ and ElastQ, and the liver fat content percentage measured by MRI
Summary
This prospective study aims to recruit pediatric patients with confirmed or suspected
 non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatosis hepatitis (NASH) and who
 are eligible for standard ultrasound and MRI examinations. All subjects will undergo a 2D
 ultrasound scan and MRI examination. Approximately 108 subjects will be enrolled, targeting
 at 90 completing the study.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06095479
Device Trial